The US Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to Zai Lab’s delta-like ligand 3 (DLL3) antibody-drug conjugate (ADC), ZL-1310, for small cell lung cancer (SCLC).

Asian equities traded in the US as American depositary receipts were edging lower on Thursday morning, down 0.2% to 2,123.24 on the S&P Asia 50 ADR Index. From North Asia, the gainers were led by ...